Harnessing bioengineered myeloid progenitors for precision immunotherapies
Willem Buys, Elias T Zambidis · 2023
Read Harnessing bioengineered myeloid progenitors for precision immunotherapies by Willem Buys, Elias T Zambidis (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10716389.txt.
Description
Buys and Zambidis review how engineered myeloid cells could serve as precise immune therapies. Granulocytes and macrophages form the innate system's front line. They kill germs and tumors and help steer later immune responses. When these cells vanish, as in newborn sepsis or after chemotherapy, infection risk soars. Beyond simple replacement, tailored cells could carry drugs to inflamed sites. Neutrophils home to inflammation by nature, a trait therapy could exploit.
Cells could also bear tumor-targeting receptors or boost killing of blood cancers. The catch is supply: these cells live briefly and are hard to harvest in bulk. Lab-grown progenitors offer a way around that limit. The review weighs promise against that practical hurdle.
Catalog record
| CREATOR | Willem Buys, Elias T Zambidis |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |